Ortho-McNeil Topamax marketing documents subpoenaed
Executive Summary
Ortho-McNeil receives subpoena from Boston U.S. Attorney's Office requesting documents related to the company's sales and marketing of its anti-epileptic Topamax (topiramate). The Boston U.S. Attorney's Office is also conducting an investigation of Parke-Davis' (now Pfizer) promotions of its anti-epileptic Neurontin (gabapentin); the whistleblower case, alleging that the company violated the False Claims Act by promoting Neurontin for off-label uses, is pending in Massachusetts federal court (1"The Pink Sheet" Oct. 13, 2003, p. 15)...